Clinical Trials Directory

Trials / Completed

CompletedNCT01721720

Genetic, Brain Structure, and Environmental Effects on ADHD

The Neurobehavioral, Environmental and Genetic Factors Impacting the Clinical Course of Attention Deficit Hyperactivity Disorder

Status
Completed
Phase
Study type
Observational
Enrollment
1,091 (actual)
Sponsor
National Human Genome Research Institute (NHGRI) · NIH
Sex
All
Age
3 Years
Healthy volunteers
Accepted

Summary

Background: \- Attention deficit hyperactivity disorder (ADHD) is one of the most common and inheritable of all neuropsychiatric disorders. It causes problems with attention and impulse control. However, the genetic component of ADHD has not been fully studied, including how genes interact with the environment. Researchers want to study children and adults who have ADHD. They will look at how genetic, brain structure, and environmental factors affect ADHD in children and adults. Objectives: \- To study genetic, brain structure, and environmental factors in ADHD in children and adults. Eligibility: \- Individuals at least 3 years of age who have ADHD. Design: * Participants will be screened with a physical exam and medical history. * Participants will be interviewed about their ADHD. They will also complete behavior and psychological tests. Parents or guardians will complete the tests along with participants under 18 years of age. * Participants will provide saliva or blood samples. * Participants will also have imaging studies of the brain. * Participants under 25 years of age will return once a year to repeat the tests. Those over 25 years of age will have only the one set of tests. Those who are starting stimulant drugs and who are receiving behavioral treatment for the first time will also have another set of tests 12 weeks after the start of treatment.

Detailed description

OBJECTIVES: This study aims to provide novel phenotypes for genomic studies into Attention- Deficit Hyperactivity Disorder (ADHD), one of the most common and heritable of all neuropsychiatric disorders. It proposes to split the disorder into neurobiologically more meaningful entities by delineating subgroups based on neurobehavioral profiles. It will also explore factors that impact clinical course, focusing on the neural effects of treatment and the role of the child s social environment. POPULATION AND DESIGN: Using a prospective longitudinal design, a group of children and adolescents with ADHD will be followed. Additionally, families that have several members affected by ADHD will be recruited. OUTCOMES: The study will link the onset and clinical course of ADHD with genotype, brain structure and function, behavior and the child s social environment.

Conditions

Timeline

Start date
2012-11-09
Primary completion
2024-07-25
Completion
2024-07-25
First posted
2012-11-06
Last updated
2024-10-16

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01721720. Inclusion in this directory is not an endorsement.